Frédérique Brockly

928 total citations
28 papers, 780 citations indexed

About

Frédérique Brockly is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Frédérique Brockly has authored 28 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Immunology. Recurrent topics in Frédérique Brockly's work include Ubiquitin and proteasome pathways (13 papers), T-cell and B-cell Immunology (7 papers) and Virus-based gene therapy research (6 papers). Frédérique Brockly is often cited by papers focused on Ubiquitin and proteasome pathways (13 papers), T-cell and B-cell Immunology (7 papers) and Virus-based gene therapy research (6 papers). Frédérique Brockly collaborates with scholars based in France, Denmark and Luxembourg. Frédérique Brockly's co-authors include Marc Piechaczyk, Guillaume Bossis, Paul Chuchana, Marie‐Paule Lefranc, Isabelle Jariel‐Encontre, Daniel Alexandre, Claire Acquaviva, Patrizia Ferrara, Antoine Blancher and Sylvie Huck and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Oncogene.

In The Last Decade

Frédérique Brockly

28 papers receiving 768 citations

Peers

Countries citing papers authored by Frédérique Brockly

Since Specialization

Citations

This map shows the geographic impact of Frédérique Brockly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérique Brockly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérique Brockly more than expected).

Fields of papers citing papers by Frédérique Brockly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédérique Brockly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérique Brockly. The network helps show where Frédérique Brockly may publish in the future.

Co-authorship network of co-authors of Frédérique Brockly

This figure shows the co-authorship network connecting the top 25 collaborators of Frédérique Brockly. A scholar is included among the top collaborators of Frédérique Brockly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédérique Brockly. Frédérique Brockly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Microbead-Based Flow Cytometry Assay to Assess the Activity of Ubiquitin and Ubiquitin-Like Conjugating Enzymes 2022 ·Methods in molecular biology ·(unknown), (unknown), Frédérique Brockly, Guillaume Bossis	1
2	Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies 2020 ·Life Science Alliance ·(unknown), Frédérique Brockly, Christelle Reynès, Manuela Pastore, Yosr Hicheri, Guillaume Cartron, Marc Piechaczyk, Guillaume Bossis	12
3	Production and Purification of Recombinant SUMOylated Proteins Using Engineered Bacteria 2016 ·Methods in molecular biology ·Frédérique Brockly, Marc Piechaczyk, Guillaume Bossis	4
4	Chromatin loop organization of the junb locus in mouse dendritic cells 2013 ·Nucleic Acids Research ·(unknown), (unknown), Franck Court, (unknown), Frédérique Brockly, Thierry Forné, Marc Piechaczyk	10
5	SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation 2013 ·Oncogene ·Denis Tempé, Éric Vivès, Frédérique Brockly, Hilary Brooks, Stefano Rossi, Marc Piechaczyk, Guillaume Bossis	44
6	Heterodimerization with Different Jun Proteins Controls c-Fos Intranuclear Dynamics and Distribution 2010 ·Journal of Biological Chemistry ·Cécile E. Malnou, Frédérique Brockly, Cyril Favard, (unknown), Marc Piechaczyk, Isabelle Jariel‐Encontre	29
7	Heterodimerization with Jun Family Members Regulates c-Fos Nucleocytoplasmic Traffic 2007 ·Journal of Biological Chemistry ·Cécile E. Malnou, (unknown), Frédérique Brockly, Harald Wodrich, Marc Piechaczyk, Isabelle Jariel‐Encontre	50
8	The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression 2003 ·Oncogene ·Patrizia Ferrara, (unknown), Guillaume Bossis, Claire Acquaviva, Frédérique Brockly, Isabelle Jariel‐Encontre, Marc Piechaczyk	59
9	Cellular and viral Fos proteins are degraded by different proteolytic systems 2001 ·Oncogene ·Claire Acquaviva, (unknown), Frédérique Brockly, Guillaume Bossis, Patrizia Ferrara, Marc Piechaczyk, Isabelle Jariel‐Encontre	15
10	Sustained Systemic Delivery of Monoclonal Antibodies by Genetically Modified Skin Fibroblasts 2000 ·Journal of Investigative Dermatology ·Danièle Noël, Mireia Pelegrín, Frédérique Brockly, Marc Piechaczyk, Anders H. Lund	13
11	Antiviral Activity of an Intracellularly Expressed Single-Chain Antibody Fragment Directed against the Murine Leukemia Virus Capsid Protein 2000 ·Human Gene Therapy ·Mariana Marin, Mireia Pelegrín, (unknown), Danièle Noël, Frédérique Brockly, Marc Piechaczyk	8
12	Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins 1996 ·Journal of Virology ·(unknown), Danièle Noël, (unknown), Frédérique Brockly, Maryse Etienne‐Julan, Stephen J. Russell, François–Loïc Cosset, Marc Piechaczyk	93
13	Cloning and Expression of a Single-Chain Antibody Fragment Specific for a Monomorphic Determinant of Class I Molecules of the Human Major Histocompatibility Complex 1995 ·Hybridoma ·Mariana Marin, Frédérique Brockly, Danièle Noël, Maryse Etienne‐Julan, (unknown), (unknown), (unknown), Marc Piechaczyk	7
14	Definition of the human immunoglobulin variable lambda (IGLV) gene subgroups 1990 ·European Journal of Immunology ·Paul Chuchana, Antoine Blancher, Frédérique Brockly, Daniel Alexandre, Gérard Lefranc, Marie‐Paule Lefranc	72
15	BamH I restriction fragment alleles of the human T-cell receptor delta (TRD) variable region V2 1989 ·Nucleic Acids Research ·Paul Chuchana, (unknown), Frédérique Brockly, (unknown), N. Ghanem, Marie‐Paule Lefranc	7
16	First genomic sequence of a human Ig variable λ gene belonging to subgroup I. Functional genes, pseudogenes and vestigial sequences are interspersed in the IGLV locus 1989 ·Nucleic Acids Research ·Daniel Alexandre, Paul Chuchana, Frédérique Brockly, Antoine Blancher, Marie‐Paule Lefranc	35
17	No preferential use of the VH(V) family in human multiple myeloma 1989 ·British Journal of Haematology ·(unknown), Frédérique Brockly, Thérèse Commes, Marie‐Paule Lefranc, Régis Bataille, Bernard Klein	3
18	Molecular mapping of the human T cell receptor gamma (TRG) genes and linkage of the variable and constant regions 1989 ·European Journal of Immunology ·Marie‐Paule Lefranc, Paul Chuchana, Piona Dariavach, Catherine Nguyen, Sylvie Huck, Frédérique Brockly, Bertrand Jordan	62
19	First nucleotide sequence of a human immunoglobulin variable λ gene belonging to subgroup II 1989 ·Nucleic Acids Research ·Frédérique Brockly, Daniel Alexandre, Paul Chuchana, Sylvie Huck, Marie‐Paule Lefranc	37
20	Molecular Cloning, Sequencing, and Expression in Escherichia coli of Human Preprourokinase cDNA 1985 ·DNA ·(unknown), Alfredo Cravador, (unknown), Frédérique Brockly, Brigitte Colau, Paul Chuchana, (unknown), A. Herzog, Alex Bollen	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact